YPHDF

Ypsomed Holding AG, along with its associated companies, specializes in the development, production, and worldwide distribution of sophisticated injection and infusion systems primarily for the pharmaceutical and biotechnology industries. The company's business is structured into two main segments: 1. Ypsomed Delivery Systems: This division focuses on providing a diverse portfolio of advanced injection solutions, including various types of pen, auto, patch, and wearable injectors, as well as other intelligent device technologies. Products from this segment are marketed under the YDS brand. 2. Ypsomed Diabetes Care: This segment is dedicated to serving individuals with diabetes by supplying and trading essential daily items. Its offerings encompass insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, and a range of related accessories. These products are available under the mylife brand. Beyond its core product lines, Ypsomed also manufactures precision turned parts and offers contract manufacturing alongside other specialized services. Its products reach global markets through strategic partnerships with biotechnology and pharmaceutical companies, complemented by the company's own distribution channels and a network of independent distributors. Ypsomed's operational footprint spans Switzerland, Europe, North America, and other international territories. Founded in 1984, Ypsomed Holding AG is headquartered in Burgdorf, Switzerland.